Several lots of the cholesterol medication atorvastatin were recalled after failed dissolution tests, according to the FDA.
On Oct. 10, the FDA classified the recalled prescription medication as a Class II recall. The risk classification from the ...
One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...
Trials of a new cholesterol-lowering pill have shown promising results for people with heterozygous familial ...
More than 140,000 bottles of a popular drug commonly prescribed to reduce cholesterol have been recalled for a defect that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback